Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02977442
Other study ID # PBRC 2018-020
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 2016
Est. completion date December 2024

Study information

Verified date June 2024
Source Pennington Biomedical Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Insulin promotes the clearance of sugars from the blood into skeletal muscle and fat cells for use as energy; it also promotes storage of excess nutrients as fat. Type 2 diabetes occurs when the cells of the body become resistant to the effects of insulin, and this causes high blood sugar and contributes to a build-up of fat in muscle, pancreas, liver, and the heart. Understanding how insulin resistance occurs will pave the way for new therapies aimed at preventing and treating type 2 diabetes. Mitochondria are cellular structures that are responsible for turning nutrients from food, into the energy that our cells run on. As a result, mitochondria are known as "the powerhouse of the cell." Mitochondria are dynamic organelles that can move within a cell to the areas where they are needed, and can fuse together to form large, string-like, tubular networks or divide into small spherical structures. The name of this process is "mitochondrial dynamics" and the process keeps the cells healthy. However, when more food is consumed compared to the amount of energy burned, mitochondria may become overloaded and dysfunctional resulting in a leak of partially metabolized nutrients that can interfere with the ability of insulin to communicate within the cell. This may be a way for the cells to prevent further uptake of nutrients until the current supply has been exhausted. However, long term overload of the mitochondria may cause blood sugar levels to rise and lead to the development of type 2 diabetes. This study will provide information about the relationship between mitochondrial dynamics, insulin resistance and type 2 diabetes.


Description:

The traditional view of mitochondria as isolated, spherical, energy producing organelles is undergoing a revolutionary transformation. Emerging data show that mitochondria form a dynamic networked reticulum that is regulated by cycles of fission and fusion. The discovery of a number of proteins that regulate these activities has led to important advances in understanding human disease. Data show that activation of dynamin related protein 1 (Drp1), a protein that controls mitochondrial fission, is reduced following exercise in prediabetes, and the decrease is linked to increased insulin sensitivity and fat oxidation. The proposed research will test the hypothesis that mitochondrial dynamics is a key mechanism of insulin resistance in type 2 diabetes. The experimental approach harnesses innovative molecular and cellular tools, interfaced with physiologically significant human studies to obtain meaningful data on insulin resistance, and has the potential to generate insights that will lead to new diabetes therapies for future generations.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 24
Est. completion date December 2024
Est. primary completion date September 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Type 2 Diabetes - Body Mass Index (BMI) between 25 and 50 kg/m2 - HbA1C < 10% - Sedentary Exclusion Criteria: - Evidence of type 1 diabetes or requiring insulin therapy - BMI >50 kg/m2 - Smoking - Active pregnancy

Study Design


Intervention

Behavioral:
exercise


Locations

Country Name City State
United States Pennington Biomedical Research Center Baton Rouge Louisiana

Sponsors (1)

Lead Sponsor Collaborator
Pennington Biomedical Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effects of exercise on mitochondrial dynamics Dynamics will be assessed from quantitative measures of dynamin-related protein-1. 5 years
Secondary Effects of exercise on mitochondrial function Function will be assessed from oxygen consumption. 5 years
Secondary Insulin sensitivity Insulin sensitivity will be assessed by euglycemic hyperinsulinemic clamp. 5 years
See also
  Status Clinical Trial Phase
Completed NCT02131948 - Regulation of Endogenous Glucose Production by Brain Insulin Action Phase 1
Terminated NCT03511521 - Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia Phase 4
Completed NCT03388697 - Validation of a Novel Screening Test for Maternal Insulin Resistance
Completed NCT03314714 - Duality of Lipids: the Athlete's Paradox N/A
Completed NCT03135015 - Acute Effect of HP-211 (Axulin) on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans Phase 1
Active, not recruiting NCT06400082 - Topical Insulin for Postoperative Wound Healing N/A